Bank of Montreal’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bank of Montreal’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-95,222	Closed	-$7.16K	–	4603
2022 Q2	$7.16K	Buy	+95,222	New	+$4.23M	﹤0.01%	1221
2021 Q2	–	Sell	-1,201	Closed	-$98K	–	5359
2021 Q1	$98K	Sell	1,201 -4,591	-79%	-$546K	﹤0.01%	3407
2020 Q4	$750K	Buy	5,792 +4,209	+266%	+$461K	﹤0.01%	2457
2020 Q3	$145K	Sell	1,583 -644	-29%	-$44.9K	﹤0.01%	2894
2020 Q2	$134K	Buy	+2,227	New	+$128K	﹤0.01%	2946
2020 Q1	–	Sell	-3,484	Closed	-$217K	–	4939
2019 Q4	$217K	Buy	3,484 +2,902	+499%	+$138K	﹤0.01%	3118
2019 Q3	$22K	Buy	582 +28	+5%	+$1.22K	﹤0.01%	4052
2019 Q2	$23K	Buy	+554	New	+$19.8K	﹤0.01%	4110

Bank of Montreal's TPTX Position: Q3 2022 in Review

Bank of Montreal sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 95,222 shares — an estimated $7.16K sold.

Bank of Montreal first reported a position in TPTX in Q2 2019 and held it in 8 quarters. The position peaked at $750K in Q4 2020. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Bank of Montreal reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Bank of Montreal sold 95,222 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $7.16K.
Bank of Montreal first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
Bank of Montreal's Turning Point Therapeutics, Inc. Common Stock position peaked at $750K in Q4 2020.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Bank of Montreal's 13F filing for Q3 2022, filed 10 Nov 2022.